JPWO2021067458A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021067458A5
JPWO2021067458A5 JP2022518653A JP2022518653A JPWO2021067458A5 JP WO2021067458 A5 JPWO2021067458 A5 JP WO2021067458A5 JP 2022518653 A JP2022518653 A JP 2022518653A JP 2022518653 A JP2022518653 A JP 2022518653A JP WO2021067458 A5 JPWO2021067458 A5 JP WO2021067458A5
Authority
JP
Japan
Prior art keywords
substituted
poly
formula
integer
aryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022518653A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022549295A (ja
JP7784993B2 (ja
JP2022549295A5 (https=
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/053572 external-priority patent/WO2021067458A1/en
Publication of JP2022549295A publication Critical patent/JP2022549295A/ja
Publication of JPWO2021067458A5 publication Critical patent/JPWO2021067458A5/ja
Publication of JP2022549295A5 publication Critical patent/JP2022549295A5/ja
Application granted granted Critical
Publication of JP7784993B2 publication Critical patent/JP7784993B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022518653A 2019-09-30 2020-09-30 タンパク質-巨大分子コンジュゲート及びその使用方法 Active JP7784993B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962908435P 2019-09-30 2019-09-30
US62/908,435 2019-09-30
PCT/US2020/053572 WO2021067458A1 (en) 2019-09-30 2020-09-30 Protein-macromolecule conjugates and methods of use thereof

Publications (4)

Publication Number Publication Date
JP2022549295A JP2022549295A (ja) 2022-11-24
JPWO2021067458A5 true JPWO2021067458A5 (https=) 2023-11-13
JP2022549295A5 JP2022549295A5 (https=) 2023-11-13
JP7784993B2 JP7784993B2 (ja) 2025-12-12

Family

ID=75337536

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022518653A Active JP7784993B2 (ja) 2019-09-30 2020-09-30 タンパク質-巨大分子コンジュゲート及びその使用方法

Country Status (13)

Country Link
US (1) US20220401561A1 (https=)
EP (1) EP4037715A4 (https=)
JP (1) JP7784993B2 (https=)
KR (1) KR20220074897A (https=)
CN (1) CN114630818A (https=)
AU (1) AU2020360397A1 (https=)
BR (1) BR112022005465A2 (https=)
CA (1) CA3153644A1 (https=)
IL (1) IL291730B2 (https=)
MX (1) MX2022003065A (https=)
TW (1) TW202126332A (https=)
WO (1) WO2021067458A1 (https=)
ZA (1) ZA202204162B (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20220109436A (ko) 2019-12-03 2022-08-04 에보텍 인터내셔널 게엠베하 인터페론-결합된 항원 결합 단백질 및 이의 용도
WO2022103983A2 (en) * 2020-11-11 2022-05-19 Sutro Biopharma, Inc. Fluorenylmethyloxycarbonyl and fluorenylmethylaminocarbonyl compounds, protein conjugates thereof, and methods for their use
AU2022249281B2 (en) * 2021-03-29 2025-08-14 Aj Sciences (Yixing) Co., Ltd Protein-macromolecule conjugates and methods of use thereof
CN113929731B (zh) * 2021-12-16 2022-05-10 北京春雷杰创生物科技有限公司 一种促进低分子量蛋白体外复性和提高免疫原性的方法
EP4539887A1 (en) * 2022-06-16 2025-04-23 Merck Sharp & Dohme LLC Interleukin-2 prodrugs
CN115947745B (zh) * 2022-12-26 2024-02-27 中山大学 一种基于白蛋白的光热转换纳米材料及其制备方法和应用
CN120737012B (zh) * 2025-08-29 2025-11-18 苏州金顶生物有限公司 一种新型保护氨基酸、制备方法及其应用

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5116943A (en) 1985-01-18 1992-05-26 Cetus Corporation Oxidation-resistant muteins of Il-2 and other protein
US4766106A (en) 1985-06-26 1988-08-23 Cetus Corporation Solubilization of proteins for pharmaceutical compositions using polymer conjugation
US5206344A (en) 1985-06-26 1993-04-27 Cetus Oncology Corporation Interleukin-2 muteins and polymer conjugation thereof
US5089261A (en) 1989-01-23 1992-02-18 Cetus Corporation Preparation of a polymer/interleukin-2 conjugate
US4902502A (en) 1989-01-23 1990-02-20 Cetus Corporation Preparation of a polymer/interleukin-2 conjugate
US5153310A (en) 1989-02-28 1992-10-06 Du Pont Merck Pharmaceutical Company Il-2 analogs containing n-linked glycosylation sites
US5635597A (en) 1994-05-27 1997-06-03 Affymax Technologies, N.V. Peptides that bind IL-2 receptors
US5932462A (en) 1995-01-10 1999-08-03 Shearwater Polymers, Inc. Multiarmed, monofunctional, polymer for coupling to molecules and surfaces
IL119029A0 (en) 1996-08-07 1996-11-14 Yeda Res & Dev Long-acting drugs and pharamaceutical compositions comprising them
DK1411075T3 (da) 1998-03-12 2008-10-27 Nektar Therapeutics Al Corp Fremgangsmåde til fremstilling af polymerkonjugater
US6168785B1 (en) 1998-07-16 2001-01-02 Institut Pasteur Biological applications of new peptides of IL-2 and derivatives and use as therapeutic agents
FR2826365B1 (fr) 2001-06-20 2003-09-26 Oreal Compositions cosmetiques photoprotectrices contenant des derives amides, sulfonamides ou carbamates aromatiques d'acrylonitrile et nouveaux derives amides, sulfonamides ou carbamates d'acrylonitrile
US20070027073A1 (en) 2003-04-08 2007-02-01 Menachem Rubinstein Long-acting derivatives of pyy agonists
WO2005007121A2 (en) 2003-07-18 2005-01-27 Massachusetts Institute Of Technology Mutant interleukin-2(il-2) polypeptides
BRPI0611872B8 (pt) 2005-06-16 2021-05-25 Nektar Therapeutics reagente polimérico, conjugado, método para preparação de um conjugado e composição farmacêutica
KR101508621B1 (ko) 2007-02-28 2015-04-07 세리나 쎄라퓨틱스, 인코포레이티드 활성화된 폴리옥사졸린 및 이를 포함하는 조성물
US7567215B1 (en) 2007-10-23 2009-07-28 The United States Of America As Represented By The Secretary Of The Navy Portable and inflatable antenna device
CN104529711B (zh) 2007-11-21 2020-02-07 乔治亚大学研究基金公司 炔烃以及炔烃与1,3-偶极-官能化合物反应的方法
WO2009158668A1 (en) 2008-06-26 2009-12-30 Prolynx Llc Prodrugs and drug-macromolecule conjugates having controlled drug release rates
US20100240773A1 (en) * 2009-03-23 2010-09-23 Kenneth Korzekwa Multifunctional linkers
EP2566335B1 (en) * 2010-05-05 2016-06-29 Prolynx Llc Controlled release of active compounds from macromolecular conjugates
US8703907B2 (en) * 2010-05-05 2014-04-22 Prolynx Llc Controlled drug release from dendrimers
EP2566334B1 (en) * 2010-05-05 2018-04-18 Prolynx, LLC Controlled drug release from solid supports
ES2866674T3 (es) 2010-11-12 2021-10-19 Nektar Therapeutics Conjugados de una fracción de IL-2 y un polímero
WO2013036857A1 (en) * 2011-09-07 2013-03-14 Prolynx Llc Sulfone linkers
KR102109067B1 (ko) * 2011-09-07 2020-05-13 프로린크스 엘엘시 생분해성 교차결합을 가지는 하이드로젤
US20140256626A1 (en) * 2011-10-18 2014-09-11 Prolynx Llc Peg conjugates of exenatide
SG10201803370XA (en) 2013-10-22 2018-06-28 Prolynx Llc Conjugates of somatostatin and its analogs
WO2016053107A1 (en) * 2014-10-03 2016-04-07 Synaffix B.V. Sulfamide linker, conjugates thereof, and methods of preparation
WO2019028419A1 (en) 2017-08-03 2019-02-07 Synthorx, Inc. CYTOKINE CONJUGATES FOR THE TREATMENT OF PROLIFERATIVE AND INFECTIOUS DISEASES
KR20220004134A (ko) 2019-04-26 2022-01-11 프로린크스 엘엘시 서방형 사이토카인 컨쥬게이트

Similar Documents

Publication Publication Date Title
AU2005232371B2 (en) Polymeric prodrug with a self-immolative linker
CN101242859B (zh) 作为聚合物缀合前药中的连接团的n,n-二(羟乙基)甘氨酰胺
ES2636741T3 (es) Composición de insulina de acción prolongada
US7417021B2 (en) Biologically active conjugate of a biopolymer and therapeutic agent
ES2371865T3 (es) Conjugados de hidroxialquilalmidón-principio activo.
US9173953B2 (en) Prodrugs containing an aromatic amine connected by an amido bond to a linker
IL291730B1 (en) Protein-macromolecule conjugates and methods of using them
JP5448854B2 (ja) オリゴマー−プロテアーゼ阻害剤複合体
CN102803297B (zh) 糖胺聚糖类(gag)与生物活性分子的缀合物的合成方法、聚合缀合物及其相关用途
SK286654B6 (sk) Spôsob postupného pripájania polyetylénglykolových častí a použitie PEG-polypeptidových konjugátov vyrobených týmto spôsobom
CA2972318A1 (en) Prodrugs of c-type natriuretic peptide(cnp)
CN103945870A (zh) 生物可降解交联的水凝胶
JP2004517040A (ja) ポリマー修飾された生物活性な合成ケモカインならびにその製造方法および使用方法
JPWO2021067458A5 (https=)
WO2001060412A2 (en) Modification of biopolymers for improved drug delivery
Wan et al. Optimizing size and copy number for PEG-fMLF (N-formyl-methionyl-leucyl-phenylalanine) nanocarrier uptake by macrophages
KR20120090961A (ko) 올리고머-칼슘 모방체 컨쥬게이트 및 관련 화합물
CN118695874A (zh) 采用tlr7/8激动剂的癌症疗法
JPWO2023009759A5 (https=)